Search research articles
Contact Us
Filters
Showing results (131-140 of 180) with videos related to
Page
of 18
Sort By:
Science Advances
|
November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLC
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
British Journal of Cancer
|
August 1, 2024
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors
Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, et al.
British Journal of Cancer
|
September 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis
Abderaouf Hamza, Pierre Gestraud, Maryam Karimi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2016
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01)
Vania Tacher, Marie-Cécile Le Deley, Antoine Hollebecque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2026
Role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung Cancer
Filippo G Dall'Olio, Wael Zrafi, Damien Vasseur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2017
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial
Anne C Harttrampf, Ludovic Lacroix, Marc Deloger, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 28, 2013
Molecular screening for a personalized treatment approach in advanced adrenocortical cancer
Maria Cristina De Martino, Abir Al Ghuzlan, Sebastien Aubert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 18, 2012
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2)
Jacques Cadranel, Audrey Mauguen, Michele Faller, et al.
Oncotarget
|
March 9, 2018
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers
Luc Cabel, Alina Fuerea, Ludovic Lacroix, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 180) with videos related to
Sort By:
Page
of 18
Science Advances
|
November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLC
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
British Journal of Cancer
|
August 1, 2024
Copy number alterations in metastatic and early breast tumours: prognostic and acquired biomarkers of resistance to CDK4/6 inhibitors
Marie-Paule Sablin, Pierre Gestraud, Sarah Flora Jonas, et al.
British Journal of Cancer
|
September 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis
Abderaouf Hamza, Pierre Gestraud, Maryam Karimi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 28, 2016
Factors associated with success of image-guided tumour biopsies: Results from a prospective molecular triage study (MOSCATO-01)
Vania Tacher, Marie-Cécile Le Deley, Antoine Hollebecque, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2026
Role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung Cancer
Filippo G Dall'Olio, Wael Zrafi, Damien Vasseur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2017
Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial
Anne C Harttrampf, Ludovic Lacroix, Marc Deloger, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 28, 2013
Molecular screening for a personalized treatment approach in advanced adrenocortical cancer
Maria Cristina De Martino, Abir Al Ghuzlan, Sebastien Aubert, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 18, 2012
Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2)
Jacques Cadranel, Audrey Mauguen, Michele Faller, et al.
Oncotarget
|
March 9, 2018
Efficacy of histology-agnostic and molecularly-driven HER2 inhibitors for refractory cancers
Luc Cabel, Alina Fuerea, Ludovic Lacroix, et al.
Page
of 18